NCT02044419View on ClinicalTrials.gov

A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 30, 2013

Primary Completion Date

December 23, 2013

Study Completion Date

December 23, 2013

Conditions
Healthy
Interventions
DRUG

lomitapide

Trial Locations (1)

CR7 7YE

Richmond Pharmacology Ltd, Croydon

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT02044419 - A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled | Biotech Hunter | Biotech Hunter